Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 1300 participants.
Also called NCT04474223
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,300 participants
- Sponsor
- Registry
-
NCT04474223
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Canada
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04474223. Allocation not applicable; no masking; primary purpose treatment. Start 2020-08-01 (actual); primary completion 2028-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
- Condition
- AVB - Atrioventricular Block
- Condition
- Fetal AVB
- Intervention (Drug)
- Dexamethasone
- Intervention (Drug)
- IVIG
- Lead sponsor
- NYU Langone Health
Record details
- Record id
cardio:ct-nct04474223- Content hash
28ab77f6c8856253ca55f65af637ef0a390e328817764e5dcdcf3b8f5e98e2f4